SEARCH

SEARCH BY CITATION

Additional Supporting Information may be found in the online version of this article.

FilenameFormatSizeDescription
HEP_24174_sm_suppinfo.doc39KSupporting Information
HEP_24174_sm_suppinfofigureS1.tif1229KSupporting Information Figure 1
HEP_24174_sm_suppinfofigureS2.tif1218KSupporting Information Figure 2
HEP_24174_sm_suppinfofigureS3.tif750KSupporting Information Figure 3
HEP_24174_sm_suppinfofigureS4.tif1085KSupporting Information Figure 4
HEP_24174_sm_suppinfofigureS5.tif1600KSupporting Information Figure 5
HEP_24174_sm_suppinfofigureS6.tif947KSupporting Information Figure 6
HEP_24174_sm_suppinfofigureS7.tif1633KSupporting Information Figure 7
HEP_24174_sm_suppinfofigureS8.tif861KSupporting Information Figure 8
HEP_24174_sm_suppinfofigureS9.tif1262KSupporting Information Figure 9
HEP_24174_sm_suppinfofigureS10.tif2733KSupporting Information Figure 10
HEP_24174_sm_suppinfotable1.doc26KSupporting Table 1. Clinicopathological features of HCC Patients
HEP_24174_sm_suppinfotable2.doc24KSupporting Table 2. List of the primary antibodies used for immunoblotting and immunoprecipitation analysis

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.